NCT03379389View on ClinicalTrials.gov

Clinical Assessment of Urinary Antiseptics Methenamine and Methylthioninium in Recurrent Cystitis

PHASE4CompletedINTERVENTIONAL
Enrollment

284

Participants

Timeline

Start Date

March 31, 2018

Primary Completion Date

May 1, 2019

Study Completion Date

June 1, 2021

Conditions
Urinary Tract Infections
Interventions
DRUG

Methenamine + Methylthioninium

Methenamine + Methylthioninium

DRUG

Methenamine + Methylthioninium + Acriflavine + Atropa belladona

Methenamine + Methylthioninium + Acriflavine + Atropa belladona

DRUG

Antibiotics

Antibiotics based on individual subjects urine culture / antibiogram

Trial Locations (1)

25964004

Centro Universitário Serra dos Órgãos - UNIFESO, Teresópolis

All Listed Sponsors
lead

Fundação Educacional Serra dos Órgãos

OTHER

NCT03379389 - Clinical Assessment of Urinary Antiseptics Methenamine and Methylthioninium in Recurrent Cystitis | Biotech Hunter | Biotech Hunter